General Information of Drug Off-Target (DOT) (ID: OT5KUZ3A)

DOT Name Chloride intracellular channel protein 3 (CLIC3)
Gene Name CLIC3
Related Disease
Bladder cancer ( )
Neoplasm ( )
Urinary bladder cancer ( )
Urinary bladder neoplasm ( )
Eclampsia ( )
Fetal growth restriction ( )
Matthew-Wood syndrome ( )
Pancreatic cancer ( )
Pancreatic ductal carcinoma ( )
Breast cancer ( )
Breast carcinoma ( )
Malignant pleural mesothelioma ( )
UniProt ID
CLIC3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3FY7; 3KJY
Pfam ID
PF13410 ; PF13409
Sequence
MAETKLQLFVKASEDGESVGHCPSCQRLFMVLLLKGVPFTLTTVDTRRSPDVLKDFAPGS
QLPILLYDSDAKTDTLQIEDFLEETLGPPDFPSLAPRYRESNTAGNDVFHKFSAFIKNPV
PAQDEALYQQLLRALARLDSYLRAPLEHELAGEPQLRESRRRFLDGDRLTLADCSLLPKL
HIVDTVCAHFRQAPIPAELRGVRRYLDSAMQEKEFKYTCPHSAEILAAYRPAVHPR
Function Can insert into membranes and form chloride ion channels. May participate in cellular growth control.
Tissue Specificity Detected in placenta (at protein level). Widely expressed. High expression is found in placenta followed by lung and heart. Low expression in skeletal muscle, kidney and pancreas.

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Bladder cancer DISUHNM0 Strong Biomarker [1]
Neoplasm DISZKGEW Strong Posttranslational Modification [2]
Urinary bladder cancer DISDV4T7 Strong Biomarker [1]
Urinary bladder neoplasm DIS7HACE Strong Biomarker [1]
Eclampsia DISWPO8U moderate Biomarker [3]
Fetal growth restriction DIS5WEJ5 moderate Biomarker [3]
Matthew-Wood syndrome DISA7HR7 moderate Biomarker [4]
Pancreatic cancer DISJC981 moderate Biomarker [5]
Pancreatic ductal carcinoma DIS26F9Q moderate Altered Expression [4]
Breast cancer DIS7DPX1 Limited Biomarker [6]
Breast carcinoma DIS2UE88 Limited Biomarker [6]
Malignant pleural mesothelioma DIST2R60 Limited Altered Expression [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Chloride intracellular channel protein 3 (CLIC3). [8]
------------------------------------------------------------------------------------
17 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [9]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [10]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Chloride intracellular channel protein 3 (CLIC3). [11]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [12]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [13]
Triclosan DMZUR4N Approved Triclosan increases the expression of Chloride intracellular channel protein 3 (CLIC3). [14]
Hydroquinone DM6AVR4 Approved Hydroquinone increases the expression of Chloride intracellular channel protein 3 (CLIC3). [15]
Ampicillin DMHWE7P Approved Ampicillin increases the expression of Chloride intracellular channel protein 3 (CLIC3). [16]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [17]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Chloride intracellular channel protein 3 (CLIC3). [18]
GSK2110183 DMZHB37 Phase 2 GSK2110183 increases the expression of Chloride intracellular channel protein 3 (CLIC3). [19]
Afimoxifene DMFORDT Phase 2 Afimoxifene increases the expression of Chloride intracellular channel protein 3 (CLIC3). [20]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [16]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [21]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [22]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [23]
Sulforaphane DMQY3L0 Investigative Sulforaphane decreases the expression of Chloride intracellular channel protein 3 (CLIC3). [24]
------------------------------------------------------------------------------------
⏷ Show the Full List of 17 Drug(s)

References

1 CLT1 targets bladder cancer through integrin 51 and CLIC3.Mol Cancer Res. 2013 Feb;11(2):194-203. doi: 10.1158/1541-7786.MCR-12-0300. Epub 2012 Nov 30.
2 Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration.Oral Oncol. 2015 Dec;51(12):1120-5. doi: 10.1016/j.oraloncology.2015.09.010. Epub 2015 Oct 17.
3 Placental CLIC3 is increased in fetal growth restriction and pre-eclampsia affected human pregnancies.Placenta. 2012 Sep;33(9):741-4. doi: 10.1016/j.placenta.2012.06.011. Epub 2012 Jul 11.
4 Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression.Dev Cell. 2012 Jan 17;22(1):131-45. doi: 10.1016/j.devcel.2011.11.008. Epub 2011 Dec 22.
5 Intracellular Ion Channels in Pancreas Cancer.Cell Physiol Biochem. 2019;53(S1):44-51. doi: 10.33594/000000193.
6 CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer.J Cell Sci. 2014 Sep 15;127(Pt 18):3893-901. doi: 10.1242/jcs.135947. Epub 2014 Jul 11.
7 Transcriptional over-expression of chloride intracellular channels 3 and 4 in malignant pleural mesothelioma.Comput Biol Chem. 2015 Dec;59 Pt A:111-6. doi: 10.1016/j.compbiolchem.2015.09.012. Epub 2015 Sep 28.
8 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
9 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
10 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
11 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
12 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
13 Transforming growth factor beta1 targets estrogen receptor signaling in bronchial epithelial cells. Respir Res. 2018 Aug 30;19(1):160. doi: 10.1186/s12931-018-0861-5.
14 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
15 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
16 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
17 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
18 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
19 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.
20 Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res. 2006 Jul 15;66(14):7334-40.
21 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
22 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
23 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
24 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.